Drugs / Miconaz
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT03833570 Background | Jan → Nov 2018 | mucositis | Hams Hamed Abdelrahman | Completed | No outcome recorded |
| — | NCT07082621 Comparator | Jan 2024 → Mar 2025 | mucositis | Hams Hamed Abdelrahman | Completed | No outcome recorded |
| — | NCT06117904 Background | Jan → Jun 2024 | mucositis | Beni-Suef University | Completed | No outcome recorded |
| — | NCT05181943 Comparator | Oct 2020 → Nov 2021 | mucositis | Alexandria University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Miconaz | “These therapies included anti-fungal agents (Miconaz oral gel), topical anesthetics and anti-inflammatory drugs (BBC oral spray), topical analgesic gel (Oracure gel), sodium...” NCT06117904 ↗3“Conventional treatment using oracure, BBC spray, miconaz three times daily” NCT05181943 ↗ “topical antifungal agents (Miconaz oral gel)” NCT07082621 ↗ |
| Route | Oral | “Miconaz oral gel” NCT07082621 ↗ |